Tag: Chen Yan
Structure Therapeutics raises USD180m in ADS offering
Biopharmaceutical company Structure Therapeutics raised USD134 million in a Nasdaq listing, offering 8.95 million American depositary shares (ADS) priced at USD15 each
KE overcomes hurdles to list back in HK
Chinese property platform KE overcame significant hurdles to complete a dual-primary listing via introduction on the HKEX with weighted voting rights (WVR) in the first such so-called “homecoming” debut in Hong Kong
Rise with the tide
Chen Yan, GC of KE Holdings, shares his experiences in adapting to China’s new personal data law
LATEST ON VANTAGE ASIA
Breaking AI impasse
Exclusive interview with Wang Sijia, IP and data compliance director at NetEase Group, exploring the key challenges to China’s AI growth
